Crossmark

Phase I trial of afatinib plus vinorelbine in Japanese patients with advanced solid tumors, including breast cancer

Crossref DOI link: https://doi.org/10.1007/s00280-015-2826-4

Published Online: 2015-08-08

Published Print: 2015-10

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Mukai, Hirofumi

Masuda, Norikazu

Ishiguro, Hiroshi

Mitsuma, Ayako

Shibata, Takashi

Yamamura, Jun

Toi, Masakazu

Watabe, Aiko

Sarashina, Akiko

Uttenreuther-Fischer, Martina

Ando, Yuichi
Funding

Funding for this research was provided by:

Boehringer Ingelheim
License Information

Text and Data Mining valid from 2015-08-08